Cargando…

Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers

Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease worldwide in part due to the concomitant obesity pandemic and insulin resistance (IR). It is increasingly becoming evident that NAFLD is a disease affecting numerous extrahepatic vital organs and regulatory p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khalifa, Olfa, Errafii, Khaoula, Al-Akl, Nayla S., Arredouani, Abdelilah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593715/ https://www.ncbi.nlm.nih.gov/pubmed/33133304 http://dx.doi.org/10.1155/2020/8822859

Ejemplares similares

Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4
por: Errafii, Khaoula, et al.
Publicado: (2021)

Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway
por: Khalifa, Olfa, et al.
Publicado: (2022)

Association of dyslipidemia, diabetes and metabolic syndrome with serum ferritin levels: a middle eastern population-based cross-sectional study
por: Al Akl, Neyla S., et al.
Publicado: (2021)

Comparative Transcriptome Analysis Reveals That Exendin-4 Improves Steatosis in HepG2 Cells by Modulating Signaling Pathways Related to Lipid Metabolism
por: Errafii, Khaoula, et al.
Publicado: (2022)

Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells
por: Khalifa, Olfa, et al.
Publicado: (2023)

Investigation of the Effect of Exendin-4 on Oleic Acid-Induced Steatosis in HepG2 Cells Using Fourier Transform Infrared Spectroscopy
por: Khalifa, Olfa, et al.
Publicado: (2022)

Simple risk score to screen for prediabetes: A cross‐sectional study from the Qatar Biobank cohort
por: Abbas, Mostafa, et al.
Publicado: (2020)

Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease
por: Sookoian, Silvia, et al.
Publicado: (2017)

Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease
por: Zaiou, Mohamed
Publicado: (2022)

The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC
por: Rusu, Ioana, et al.
Publicado: (2022)

Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease
por: Huang, Ruixian, et al.
Publicado: (2019)

The impact and role of identified long noncoding RNAs in nonalcoholic fatty liver disease: A narrative review
por: Shi, Na, et al.
Publicado: (2023)

MicroRNAs in Nonalcoholic Fatty Liver Disease
por: Baffy, György
Publicado: (2015)

A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease
por: Tan, Youwen, et al.
Publicado: (2014)

High plasma salivary α-amylase, but not high AMY1 copy number, associated with low obesity rate in Qatari adults: cross-sectional study
por: Al-Akl, Neyla, et al.
Publicado: (2020)

Reduced odds of diabetes associated with high plasma salivary α-amylase activity in Qatari women: a cross-sectional study
por: Al-Akl, Neyla S., et al.
Publicado: (2021)

Elevated levels of salivary α- amylase activity in saliva associated with reduced odds of obesity in adult Qatari citizens: A cross-sectional study
por: Al-Akl, Neyla, et al.
Publicado: (2022)

Long noncoding RNAs associated with nonalcoholic fatty liver disease in a high cholesterol diet adult zebrafish model
por: An, Hyo Jung, et al.
Publicado: (2021)

MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Fang, Zhiqiang, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease: Diagnostic biomarkers
por: Hadizadeh, Fatemeh, et al.
Publicado: (2017)

The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease
por: Hernandez Roman, Jose, et al.
Publicado: (2020)

Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease
por: Obika, Mikako, et al.
Publicado: (2012)

Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC
por: Li, Yilin, et al.
Publicado: (2023)

The triglyceride glucose-waist-to-height ratio outperforms obesity and other triglyceride-related parameters in detecting prediabetes in normal-weight Qatari adults: A cross-sectional study
por: Al Akl, Neyla S., et al.
Publicado: (2023)

Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Caussy, Cyrielle, et al.
Publicado: (2020)

Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
por: Jayasekera, Dulshan, et al.
Publicado: (2023)

Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2023)

Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
por: Yang, Hye Ran
Publicado: (2013)

Noninvasive Markers for the Diagnosis of Nonalcoholic Fatty Liver Disease
por: Kim, Sang Yong
Publicado: (2013)

Clinical Manifestations and Diagnosis of Nonalcoholic Fatty Liver Disease
por: Khoonsari, Mahmoodreza, et al.
Publicado: (2017)

The role and possible mechanism of the long noncoding RNA LINC01260 in nonalcoholic fatty liver disease
por: Ge, Xiaoxiao, et al.
Publicado: (2022)

MicroRNAs or Long Noncoding RNAs in Diagnosis and Prognosis of Coronary Artery Disease
por: Zhang, Yuan, et al.
Publicado: (2019)

Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Han, Man-Hoon, et al.
Publicado: (2020)

Use of Mac‐2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis
por: Kamada, Yoshihiro, et al.
Publicado: (2017)

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
por: Pirola, Carlos J, et al.
Publicado: (2018)

Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease
por: Jiang, Hua, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
por: Chrysavgis, Lampros, et al.
Publicado: (2020)

CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE
por: Virović Jukić, Lucija, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
por: Dorairaj, Vicneswarry, et al.
Publicado: (2021)

Association of liver biomarkers and cytokeratin-18 in Nonalcoholic fatty liver disease patients
por: Altaf, Benash, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vdevh3cu4rp4jf86pr57vvktue